Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Title||Treatment With Nivolumab and Ipilimumab or Nivolumab Alone According to the Percentage of Tumoral CD8 Cells in Advanced Metastatic Cancer|
|Recruitment||Active, not recruiting|
|Sponsors||Parker Institute for Cancer Immunotherapy|
|Age Groups:||adult | senior|